HUNTINGTON MEDICAL RESEARCH INSTITUTES
🇺🇸United States
Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)
Completed
- Conditions
- Concussion, Mild
- First Posted Date
- 2014-02-24
- Last Posted Date
- 2017-11-08
- Lead Sponsor
- Huntington Medical Research Institutes
- Target Recruit Count
- 44
- Registration Number
- NCT02069613
- Locations
- 🇺🇸
Huntington Medical Research Institutes, Pasadena, California, United States
🇺🇸HMRI, Pasadena, California, United States
🇺🇸Molecular Neurology Program, Pasadena, California, United States
Minocycline in Patients With Alzheimer's Disease
Phase 2
Completed
- Conditions
- Mild Cognitive ImpairmentAlzheimer's Disease
- Interventions
- First Posted Date
- 2011-11-01
- Last Posted Date
- 2014-09-25
- Lead Sponsor
- Huntington Medical Research Institutes
- Target Recruit Count
- 13
- Registration Number
- NCT01463384
- Locations
- 🇺🇸
Huntington Medical Research Institutes, Pasadena, California, United States
Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
- First Posted Date
- 2009-07-17
- Last Posted Date
- 2010-06-10
- Lead Sponsor
- Huntington Medical Research Institutes
- Target Recruit Count
- 40
- Registration Number
- NCT00941642
- Locations
- 🇺🇸
HMRI - Liver Center, Pasadena, California, United States
A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B
Phase 2
- Conditions
- Hepatitis B
- Interventions
- Drug: IFN-γ 1b (Actimmune)Drug: IFN-γ 1b and Adefovir dipivoxil combination
- First Posted Date
- 2008-09-16
- Last Posted Date
- 2010-10-21
- Lead Sponsor
- Huntington Medical Research Institutes
- Target Recruit Count
- 30
- Registration Number
- NCT00753467
- Locations
- 🇺🇸
Huntington Medical Research Institutes, Pasadena, California, United States
© Copyright 2025. All Rights Reserved by MedPath